186 related articles for article (PubMed ID: 19998046)
61. Electron-beam technique and skin reaction of postoperative irradiation of axilla and supraclavicular nodes in breast carcinoma.
Khan FR; Bohorquez JF; Ovadia J; Nickson JJ
Radiology; 1970 May; 95(2):417-20. PubMed ID: 4985763
[No Abstract] [Full Text] [Related]
62. Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
Yee C; Wang K; Asthana R; Drost L; Lam H; Lee J; Vesprini D; Leung E; DeAngelis C; Chow E
Clin Breast Cancer; 2018 Oct; 18(5):e825-e840. PubMed ID: 30072193
[TBL] [Abstract][Full Text] [Related]
63. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
[TBL] [Abstract][Full Text] [Related]
64. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
65. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings.
Porock D; Kristjanson L
Eur J Cancer Care (Engl); 1999 Sep; 8(3):143-53. PubMed ID: 10763645
[TBL] [Abstract][Full Text] [Related]
66. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.
Rahimi A; Mohamad O; Albuquerque K; Kim DWN; Chen D; Thomas K; Wooldridge R; Rivers A; Leitch M; Rao R; Haley B; Ahn C; Garwood D; Spangler A
Support Care Cancer; 2020 Mar; 28(3):1481-1489. PubMed ID: 31273506
[TBL] [Abstract][Full Text] [Related]
67. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy.
Lee TF; Sung KC; Chao PJ; Huang YJ; Lan JH; Wu HY; Chang L; Ting HM
PLoS One; 2018; 13(7):e0200192. PubMed ID: 30011291
[TBL] [Abstract][Full Text] [Related]
68. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers.
Carter DL; Hebert ME; Smink K; Leopold KA; Clough RL; Brizel DM
Head Neck; 1999 Dec; 21(8):760-6. PubMed ID: 10562690
[TBL] [Abstract][Full Text] [Related]
69. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
[TBL] [Abstract][Full Text] [Related]
70. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group.
O'Brien PC; Franklin CI; Poulsen MG; Joseph DJ; Spry NS; Denham JW
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):442-9. PubMed ID: 12243820
[TBL] [Abstract][Full Text] [Related]
71. Prevention of skin reactions due to teletherapy in women with breast cancer: a comprehensive review.
de Andrade M; Clapis MJ; do Nascimento TG; Gozzo Tde O; de Almeida AM
Rev Lat Am Enfermagem; 2012; 20(3):604-11. PubMed ID: 22991125
[TBL] [Abstract][Full Text] [Related]
72. Subcutaneous spacer injection to reduce skin toxicity in breast brachytherapy: A pilot study on mastectomy specimens.
Struik GM; Pignol JP; Kolkman-Deurloo IK; Godart J; Verduijn GM; Koppert LB; Birnie E; Ghandi A; Klem TM
Brachytherapy; 2019; 18(2):204-210. PubMed ID: 30528494
[TBL] [Abstract][Full Text] [Related]
73. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors.
Borm KJ; Loos M; Oechsner M; Mayinger MC; Paepke D; Kiechle MB; Combs SE; Duma MN
Radiat Oncol; 2018 Nov; 13(1):218. PubMed ID: 30404664
[TBL] [Abstract][Full Text] [Related]
74. Vitamin E analogues reduce the incidence of ventricular fibrillations and scavenge free radicals.
Walker MK; Vergely C; Lecour S; Abadie C; Maupoil V; Rochette L
Fundam Clin Pharmacol; 1998; 12(2):164-72. PubMed ID: 9565770
[TBL] [Abstract][Full Text] [Related]
75. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial.
Martenson JA; Bollinger JW; Sloan JA; Novotny PJ; Urias RE; Michalak JC; Shanahan TG; Mailliard JA; Levitt R
J Clin Oncol; 2000 Mar; 18(6):1239-45. PubMed ID: 10715293
[TBL] [Abstract][Full Text] [Related]
76. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
Makkonen TA; Boström P; Vilja P; Joensuu H
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
[TBL] [Abstract][Full Text] [Related]
77. Evidence-based skin care management in radiation therapy.
McQuestion M
Semin Oncol Nurs; 2006 Aug; 22(3):163-73. PubMed ID: 16893745
[TBL] [Abstract][Full Text] [Related]
78. The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.
Zygogianni A; Kouloulias V; Antypas C; Armpilia C; Kyrgias G; Kouvaris J
Breast J; 2014; 20(1):74-8. PubMed ID: 24237451
[TBL] [Abstract][Full Text] [Related]
79. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
Sanguineti G; Franzone P; Marcenaro M; Foppiano F; Vitale V
Strahlenther Onkol; 2003 Jul; 179(7):464-70. PubMed ID: 12835883
[TBL] [Abstract][Full Text] [Related]
80. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy.
Hanna YM; Baglan KL; Stromberg JS; Vicini FA; A Decker D
Breast J; 2002; 8(3):149-53. PubMed ID: 12047471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
